A Clinical Study of Epilepsy Localization and Prognosis Based on PET and Resting-state fMRI

Li Shuangshuang

Status

Not yet enrolling

Conditions

Epileptic Seizure

Treatments

Other: No intervention

Study type

Observational

Funder types

Other

Identifiers

NCT05567042

20222137

Details and patient eligibility

About

By following up the prognosis of surgical patients, the application value of Cortex ID quantitative analysis in the localization of epilepsy foci was studied.
By studying the correlation between autonomic nerve function and epilepsy neural network in epilepsy patients, and analyzing the differences between different epilepsy patients, it can provide more information for judging the prognosis of epilepsy patients.

Full description

This study included diagnostic trials and case-control studies, which were observational studies with no intervention. First, the demographic and clinical information of epilepsy patients in the Neurology Department of Xijing Hospital were collected, including gender, age, age of onset, course of epilepsy, seizure performance before treatment, seizure frequency before treatment, type and dose of antiepileptic drugs, past history, Family history, etc., as well as imaging, EEG, quality of life, and neuropsychological assessment, etc. were collected; secondly, functional magnetic resonance imaging (fMRI) and 24-hour Holter monitoring were performed on patients who met the inclusion criteria. Positron Emission Computed Tomography (PET) images of patients who have undergone or plan to undergo surgery are analyzed; finally, appropriate statistical methods are used for analysis.

Enrollment

50 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

Meet the diagnostic criteria for epilepsy,

No contraindications for fMRI examination.
The patient had no other heart and lung diseases except epilepsy.
Patients and their families were aware of this study and signed informed consent.

Exclusion criteria

Patients with severe infection, cerebrovascular disease, malignant tumor and other systemic diseases that can affect the nervous system, and those with serious dysfunction of the heart, liver, kidney and other organs.
Non-epileptic seizures such as syncope and hysteria.
Pregnant or lactating women. Incomplete clinical data